Drug Shortage Report for TEVA-FULVESTRANT INJECTION

Last updated on 2020-02-26 History
Report ID 104353
Drug Identification Number 02460130
Brand name TEVA-FULVESTRANT INJECTION
Common or Proper name FULVESTRANT INJECTION 50MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FULVESTRANT
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5ML
ATC code L02BA
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-01-22
Estimated end date 2020-02-29
Actual end date 2020-02-25
Shortage status Resolved
Updated date 2020-02-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-02-26 English Compare
v5 2020-02-25 French Compare
v4 2020-02-25 English Compare
v3 2020-02-25 English Compare
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare

Showing 1 to 6 of 6